ZA981178B - Bicyclic aromatic amino acids - Google Patents

Bicyclic aromatic amino acids

Info

Publication number
ZA981178B
ZA981178B ZA981178A ZA981178A ZA981178B ZA 981178 B ZA981178 B ZA 981178B ZA 981178 A ZA981178 A ZA 981178A ZA 981178 A ZA981178 A ZA 981178A ZA 981178 B ZA981178 B ZA 981178B
Authority
ZA
South Africa
Prior art keywords
amino acids
aromatic amino
bicyclic aromatic
bicyclic
acids
Prior art date
Application number
ZA981178A
Inventor
Beate Diefenbach
Joachim Maerz
Friedrich Rippmann
Simon Goodman
Peter Raddatz
Matthias Wiesner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA981178B publication Critical patent/ZA981178B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA981178A 1997-02-13 1998-02-12 Bicyclic aromatic amino acids ZA981178B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19705450A DE19705450A1 (en) 1997-02-13 1997-02-13 Bicyclic aromatic amino acids

Publications (1)

Publication Number Publication Date
ZA981178B true ZA981178B (en) 1999-05-21

Family

ID=7820093

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981178A ZA981178B (en) 1997-02-13 1998-02-12 Bicyclic aromatic amino acids

Country Status (25)

Country Link
EP (1) EP0964856B1 (en)
JP (1) JP4327257B2 (en)
KR (1) KR20000071030A (en)
CN (1) CN1085205C (en)
AR (1) AR010894A1 (en)
AT (1) ATE225776T1 (en)
AU (1) AU735313B2 (en)
BR (1) BR9807345A (en)
CA (1) CA2280727C (en)
CY (1) CY2341B1 (en)
CZ (1) CZ297366B6 (en)
DE (2) DE19705450A1 (en)
DK (1) DK0964856T3 (en)
ES (1) ES2183332T3 (en)
HU (1) HUP0001138A3 (en)
ID (1) ID22533A (en)
NO (1) NO313289B1 (en)
PL (1) PL335101A1 (en)
PT (1) PT964856E (en)
RU (1) RU2187506C2 (en)
SI (1) SI0964856T1 (en)
SK (1) SK284646B6 (en)
TR (1) TR199901962T2 (en)
WO (1) WO1998035949A1 (en)
ZA (1) ZA981178B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063790A1 (en) * 1996-05-31 2004-04-01 The Scripps Research Institute Methods for inhibition of angiogenesis
CN1140511C (en) 1998-04-09 2004-03-03 明治制果株式会社 Amino piperidine derivatives as integrin alpha beta 3 antagonists
CA2368049A1 (en) 1999-04-13 2000-10-19 Basf Aktiengesellschaft Integrin receptor ligands
WO2001010844A1 (en) 1999-08-05 2001-02-15 Meiji Seika Kaisha, Ltd. φ-AMINO-α-HYDROXYCARBOXYLIC ACID DERIVATIVES HAVING INTEGRIN αvβ3 ANTAGONISM
US20030199571A1 (en) * 1999-12-24 2003-10-23 Gordon Bruton (Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives
DE60101351T2 (en) * 2000-01-25 2004-10-07 Kaneka Corp METHOD FOR PRODUCING OPTICALLY ACTIVE, N-SUBSTITUTED AZETIDINE-2-CARBONIC ACIDS
JP5054274B2 (en) 2000-11-01 2012-10-24 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Methods and compositions for treating eye diseases
RU2294192C2 (en) 2001-05-30 2007-02-27 Дзе Скриппс Рисерч Инститьют Nucleic acid delivery system
PL207175B1 (en) * 2001-08-01 2010-11-30 Merck Patent Gmbh Integrin inhibitors for the treatment of eye diseases
AU2003208833A1 (en) * 2002-02-14 2003-09-04 Merck Patent Gmbh Methods and compositions for the treatment of eye diseases
DE10305784A1 (en) * 2003-02-12 2004-08-26 Merck Patent Gmbh 3-Oxo-3,4-dihydro-2H-benz-(1,4)-oxazin-6-yl)-propionic acid derivative preparation, for use as integrin inhibitors with e.g. antitumor action, by multi-stage process giving diastereomerically pure product
DE10337863A1 (en) 2003-08-18 2005-03-17 Merck Patent Gmbh Use of chromene-4-one derivatives
AU2005249586B2 (en) * 2004-06-04 2010-12-23 The Scripps Research Institute Compositions and methods for treatment of neovascular diseases
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
ES2620446T3 (en) * 2008-12-26 2017-06-28 Sumitomo Dainippon Pharma Co., Ltd. New bicyclic heterocyclic compound
WO2011024987A1 (en) * 2009-08-31 2011-03-03 塩野義製薬株式会社 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same
US9662339B2 (en) 2012-03-06 2017-05-30 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production for combination therapy
TW201416354A (en) 2012-07-17 2014-05-01 Boehringer Ingelheim Int Inhibitors of leukotriene production
WO2015009609A1 (en) 2013-07-15 2015-01-22 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
WO2015009611A1 (en) 2013-07-15 2015-01-22 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
BR112016027778A2 (en) 2014-05-30 2017-08-15 Pfizer USES OF CARBONITRIL DERIVATIVES, THEIR COMBINATION AND THEIR PHARMACEUTICAL COMPOSITION
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
AU2022376563A1 (en) 2021-11-01 2023-12-07 Alkahest, Inc. Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0673247A4 (en) * 1992-12-01 1996-05-01 Merck & Co Inc Fibrinogen receptor antagonists.
WO1995032710A1 (en) * 1994-05-27 1995-12-07 Merck & Co., Inc. Compounds for inhibiting osteoclast-mediated bone resorption
DE19548709A1 (en) * 1995-12-23 1997-07-03 Merck Patent Gmbh Tyrosine derivatives
DE19654483A1 (en) * 1996-06-28 1998-01-02 Merck Patent Gmbh Phenylalanine derivatives
KR20000022190A (en) * 1996-06-28 2000-04-25 플레믹 크리스티안 Phenylalamine derivatives as integrin inhibitors

Also Published As

Publication number Publication date
DE19705450A1 (en) 1998-08-20
DE59805895D1 (en) 2002-11-14
JP2001511789A (en) 2001-08-14
TR199901962T2 (en) 1999-12-21
CA2280727C (en) 2008-05-06
NO993901D0 (en) 1999-08-12
HUP0001138A2 (en) 2001-05-28
CN1085205C (en) 2002-05-22
SI0964856T1 (en) 2003-04-30
ATE225776T1 (en) 2002-10-15
ES2183332T3 (en) 2003-03-16
PL335101A1 (en) 2000-04-10
EP0964856B1 (en) 2002-10-09
AU6620698A (en) 1998-09-08
CY2341B1 (en) 2004-02-06
SK284646B6 (en) 2005-08-04
NO993901L (en) 1999-10-12
CN1252064A (en) 2000-05-03
CZ297366B6 (en) 2006-11-15
WO1998035949A1 (en) 1998-08-20
CZ287599A3 (en) 1999-11-17
PT964856E (en) 2003-02-28
AR010894A1 (en) 2000-07-12
DK0964856T3 (en) 2003-02-10
SK107199A3 (en) 2000-05-16
AU735313B2 (en) 2001-07-05
HUP0001138A3 (en) 2002-10-28
ID22533A (en) 1999-10-28
EP0964856A1 (en) 1999-12-22
NO313289B1 (en) 2002-09-09
KR20000071030A (en) 2000-11-25
JP4327257B2 (en) 2009-09-09
BR9807345A (en) 2000-03-21
CA2280727A1 (en) 1998-08-20
RU2187506C2 (en) 2002-08-20

Similar Documents

Publication Publication Date Title
ZA981178B (en) Bicyclic aromatic amino acids
PT1090128E (en) Modified vitamin-k-dependent polypeptides
HU9801045D0 (en) Substituted diamino-carboxylic acids
GB9724783D0 (en) Novel polypeptides
EP1080182A4 (en) Amino acid modified polypeptides
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
PL332553A1 (en) 3-alkooxyisooxazol-4-yl-substituted 2-aminocarboxylic acids
GB9718110D0 (en) Peptides
EP1018551A4 (en) Megsin protein
GB9700154D0 (en) Peptides
ZA984322B (en) Sucrose-binding proteins
EP0996457A4 (en) Fsh-releasing peptides
GB9720784D0 (en) Protein
CZ135099A3 (en) Nalpha-2-(4-nitrophenylsulfonyl)ethoxycarbonylated amino acids
GB9701024D0 (en) Peptides
GB9706556D0 (en) Peptides
GB9713146D0 (en) Peptides
GB9703103D0 (en) Protein
GB9719670D0 (en) Protein
GB9720785D0 (en) Protein
GB9703850D0 (en) Novel protein
GB9703827D0 (en) Novel protein
GB9714075D0 (en) Novel protein
GB9706119D0 (en) Novel protein